Pharmacogenetics of the anti-HCV drug sofosbuvir: a preliminary study
Abstract Background Sofosbuvir is a potent nucleotide HCV NS5B polymerase inhibitor that is also a P-glycoprotein (encoded by the ABCB1 gene) and breast cancer resistance protein (encoded by the ABCG2 gene) substrate. Concerning previous anti-HCV therapies, pharmacogenetics had a significant impact,...
Saved in:
Published in | Journal of antimicrobial chemotherapy Vol. 73; no. 6; pp. 1659 - 1664 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Oxford University Press
01.06.2018
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!